DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common

Information source: NIH AIDS Clinical Trials Information Service
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Mycoses; HIV Infections; Coccidioidomycosis

Intervention: Fluconazole (Drug)

Phase: N/A

Status: Completed

Sponsored by: Pfizer

Summary

To compare the efficacy of fluconazole versus placebo in preventing the development of active coccidioidomycosis and other systemic fungal infections among HIV-infected patients with CD4 lymphocyte counts < 250 cells/mm3 who are living in the coccidioidal endemic area.

Clinical Details

Official title: A Double-Blind, Placebo-Controlled Study of Fluconazole in the Prevention of Active Coccidioidomycosis and Other Systemic Fungal Infections in HIV-Infected Patients Living in the Coccidioidal Endemic Area

Study design: Treatment, Parallel Assignment, Efficacy Study

Detailed description: Patients are randomized to receive either fluconazole or placebo daily.

Eligibility

Minimum age: 13 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria

Patients must have:

- Documented HIV infection.

- CD4 count < 250 cells/mm3.

- No active coccidioidomycosis or other fungal disease requiring systemic antifungal

therapy.

- Residence in area considered to be endemic for Coccidioides immitis.

- Consent of parent or guardian if under legal age of consent.

Exclusion Criteria

Co-existing Condition:

Patients with the following symptoms or conditions are excluded:

- Unable to take oral medication.

- Positive serum cryptococcal antigen.

Concurrent Medication:

Excluded:

- Systemic antifungal therapy.

Patients with the following prior conditions are excluded:

History of hypersensitivity to azole or imidazole compounds.

Prior Medication:

Excluded:

- Systemic antifungal agents within 2 weeks prior to study entry.

Locations and Contacts

McDowell Clinic, Phoenix, Arizona 85006, United States

Tucson Veterans Administration Med Ctr, Tucson, Arizona 85723, United States

Dr Lawrence Cone, Rancho Mirage, California 92270, United States

Additional Information


Last updated: June 23, 2005

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009